en آمار و اپیدمیولوژی معلولیت‌های ناشی از جنگ/حادثه Epidemiology and Statistics of War/Accident Related Injuries توصیفی و نظرسنجی Descriptive & Survey <span style="font-size:11pt"><span style="line-height:normal"><span style="unicode-bidi:embed"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:10.0pt"><span cambria="" style="font-family:"><span style="color:#ed7d31">Aims:</span></span></span></b><span style="font-size:10.0pt"><span cambria="" style="font-family:"> There are controversies about the expenditures imposed on surveillance in the treatment of elderly patients and patients with end-stage disease. The present health economic evaluation study was performed to find the cost-effectiveness of hospitalization and antiviral treatment of COVID-19 in elderly patients. </span></span></span></span></span></span><br> <span style="font-size:11pt"><span style="line-height:normal"><span style="unicode-bidi:embed"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:10.0pt"><span cambria="" style="font-family:"><span style="color:#ed7d31">Instrument & Methods:</span></span></span></b> <span style="font-size:10.0pt"><span cambria="" style="font-family:">A health economic evaluation as a single-center primary study with a cross-sectional design was performed in Firoozgar Hospital, Tehran, Iran, in 2022. All the hospitalized cases of COVID-19 at 65 years of age and more were eligible for the study. The health outcomes were the length of stay and death. Cost-effectiveness was calculated using the incremental cost-effectiveness ratio. Stata14 was used for data analysis.</span></span></span></span></span></span><br> <span style="font-size:11pt"><span style="line-height:normal"><span style="unicode-bidi:embed"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:10.0pt"><span cambria="" style="font-family:"><span style="color:#ed7d31">Findings:</span></span></span></b><span style="font-size:10.0pt"><span cambria="" style="font-family:"> Of the admitted patients, 347 cases over 65 were selected for the study. 173 patients (49.86%) were in the age range of 65-74, 69 patients (31.41%) were in the age range of 75-84, and 65 patients (18.73%) were 85 and more. One hundred ninety-nine patients (57.35%) survived, and 148 patients (42.65%) died. The mean of LoS was 11.40&plusmn;7.01 days, with the mean at the ward being 5.24&plusmn;5.44 days and at the ICU 6.15&plusmn;6.94 days. The mean cost of a bed day was 35.41&plusmn;32.03 dollars, with a right-skewed distribution.</span></span></span></span></span></span><br> <span style="font-size:11pt"><span style="line-height:normal"><span style="unicode-bidi:embed"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:10.0pt"><span cambria="" style="font-family:"><span style="color:#ed7d31">Conclusion:</span></span></span></b><span style="font-size:10.0pt"><span cambria="" style="font-family:"> A mean cost of 88.711$ is needed for the survival of one patient, assuming that all the ICU-needed patients would die if there was a lack of hospital admission. Considering all ward and ICU admitted patients, 44.854$ is needed to save one old patient&#39;s life, assuming this logic.</span></span></span></span></span></span> Health Economics,Cost-Effectiveness,Healthcare Providers, 435 439 http://ijwph.ir/browse.php?a_code=A-10-2132-1&slc_lang=en&sid=1 F. Tavassoli 15300319475328460027538 15300319475328460027538 No Student Research Committee, Iran University of Medical Sciences, Tehran, Iran A. Aghabiklooei 15300319475328460027539 15300319475328460027539 No “Firoozgar Clinical Research Development Center (FCRDC)” and “Department of Forensic Medicine, Faculty of Medicine”, Iran University of Medical Sciences, Tehran, Iran M. Azimi 15300319475328460027540 15300319475328460027540 No “Firoozgar Clinical Research Development Center (FCRDC)” and “Department of Internal Medicine, Faculty of Medicine”, Iran University of Medical Sciences, Tehran, Iran M. Baghai Wadji 15300319475328460027541 15300319475328460027541 No “Firoozgar Clinical Research Development Center (FCRDC)” and “Department of Surgery, Faculty of Medicine”, Iran University of Medical Sciences, Tehran, Iran S.A.Y. Ahmadi 15300319475328460027542 15300319475328460027542 No “Preventive Medicine and Public Health Research Center” and “Psychosocial Health Research Institute”, Iran University of Medical Sciences, Tehran, Iran M. Ameri 15300319475328460027543 15300319475328460027543 Yes “Firoozgar Clinical Research Development Center (FCRDC)” and “Department of Forensic Medicine, Faculty of Medicine”, Iran University of Medical Sciences, Tehran, Iran